The last drug designed to more effectively treat dangerous systemic fungal infections, most often affecting immunocompromised patients, was developed more than 20 years ago. Now an interdisciplinary team of...
The last drug designed to more effectively treat dangerous systemic fungal infections, most often affecting immunocompromised patients, was developed more than 20 years ago. Now an interdisciplinary team of...
© 2021 Stony Brook University
Get the latest word on Stony Brook news, discoveries and people.